Seeking Alpha

Allos Therapeutics, Inc. (ALTH)

()

News & PR
Market Currents

Buzz
Twitter: ALTH

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

Buyout Buzz at ASH Hematology Confab

Dec 7 • Michael Becker • 1 Comment
Equities Update: Mostly Flat on a Light Day

Dec 7 • Midnight Trader • 4 Comments
Celgene's Gloucester Buy: Finding Opportunity in Blood Cancer Treatment

Dec 7 • EP Vantage • Comment!
13 Biotechs to Watch for at Hematology Conference

Nov 30 • Michael Becker • Comment!
Movers and Shakers Include Flu Stocks Sinovac and BioCryst Pharma

Oct 14 • M. E. Garza • 4 Comments
Access Pharma: MuGard, Pipeline Make for Appealing Acquisition Possibilities

Sep 30 • Mike Havrilla • 4 Comments
BioMed News Bytes: NicOx, Allos, Pressure BioSciences, YM BioSciences

Sep 25 • Mike Havrilla • 2 Comments
Wednesday Options Update: ERTS, MSFT, ALTH & MT

Sep 23 • Andrew Wilkinson • Comment!
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers

Sep 20 • Justin M. Hall • 3 Comments
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up

Sep 11 • Justin M. Hall • 23 Comments
Market Jitters Affect Allos

Sep 6 • EP Vantage • 2 Comments
Allos Therapeutics: Prospects for FDA Approval of Folotyn Are Healthy

Sep 4 • M. E. Garza • 1 Comment
Will the FDA Approve Allos Therapeutics' New Cancer Drug?

Sep 4 • Prohost Biotech • Comment!
Closing Update for Thursday, Sept. 3: Market Modesty

Sep 3 • Midnight Trader • 6 Comments
Five Drug Makers with Pending Catalysts

Sep 1 • Justin M. Hall • 46 Comments
Friday Options Recap

Aug 28 • Frederic Ruffy • Comment!
FDA Calendar: 2H09 Binary Event Trades

Jul 27 • Mike Havrilla • 3 Comments
Biotech ETFs Surge Again on M&A News

Jul 24 • Michael Johnston • Comment!
Monday Options Recap

Jul 20 • Frederic Ruffy • 1 Comment
Access Pharma: Deep Pipeline, Shallow Valuation

Jul 15 • Mike Havrilla • 2 Comments
FDA Calendar Updates: King Pharma, Pain Therapeutics

Jul 8 • Mike Havrilla • 6 Comments
FDA Calendar: 18 Hot Summer Trades

Jun 16 • Mike Havrilla • 4 Comments
Wednesday's Options Recap

Jun 10 • Frederic Ruffy • Comment!
Tuesday Options Update: GLD, LEA, ALTH, MS, FXI, XHB, EEM, BNI

Jun 9 • Andrew Wilkinson • Comment!
FDA, Clinical Trial Calendars: Cancer Drug Updates from ASCO

Jun 1 • Mike Havrilla • 2 Comments
FDA, Clinical Trial Updates: MAP Pharma, Cytokinetics, Hemispherx Post Big Gains

May 27 • Mike Havrilla • 1 Comment
Clinical Trial Updates: Cancer Drugs in Focus as ASCO Approaches

May 18 • Mike Havrilla • 1 Comment
Where the Big Money Is Betting Big

May 15 • Andrew Mickey • 45 Comments
Upcoming FDA Decisions and Clinical Trials: Prevacid Goes OTC, Swine Flu Test

May 15 • Mike Havrilla • Comment!
Allos Therapeutics: Smallcap Biotech with FDA Catalyst

Apr 27 • Mike Havrilla • 1 Comment
FDA, Clinical Trial Calendar Updates: Thoratec, Allos Therapeutics

Apr 21 • Mike Havrilla • Comment!
FDA and Clinical Trial Updates: Dyax Secures Narrow Approval for Kalbitor

Mar 26 • Mike Havrilla • Comment!
20 'Bathwater Babies' and 3 'Dogs with Fleas' for the Week

Mar 2 • J Clinton Hill • 5 Comments
'When There's Blood in the Streets', Buy Biotech Stocks

Oct 10, 2008 • Ohad Hammer • 13 Comments
Allos Therapeutics Looks Promising Ahead of Crucial 6 Months

Jul 15, 2008 • EP Vantage • Comment!
Memorial Weekend Pharma Financing

May 25, 2008 • Eben Tessari • Comment!
Cancer Stocks: The Bleeding Slows

Jul 2, 2007 • Alan Brochstein • Comment!

Allos Therapeutics, Inc. (ALTH)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers